Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
about
Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines.Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse PrognosisSignalling mechanisms that regulate metabolic profile and autophagy of acute myeloid leukaemia cells
P2860
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@en
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@nl
type
label
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@en
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@nl
prefLabel
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@en
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@nl
P2093
P2860
P1476
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
@en
P2093
Agostino Tafuri
Haeun Yang
Kazumasa Sekihara
P2860
P304
P356
10.1080/14728222.2017.1333600
P407
P577
2017-05-24T00:00:00Z